New Jersey 2024-2025 Regular Session

New Jersey Senate Bill SCR38

Introduced
1/9/24  
Refer
1/9/24  

Caption

Urges Governor to direct all relevant State departments and agencies to help decrease number of fatalities caused by atherosclerotic cardiovascular disease.

Impact

The bill emphasizes the necessity for state agencies to review and update existing policies regarding cardiovascular health to improve care for patients experiencing ASCVD. Among its directives, the resolution encourages partnerships with federal and national organizations to ensure comprehensive health monitoring and treatment for at-risk populations. By advocating for heightened awareness and proactive health strategies, SCR38 aims to significantly lower the rate of cardiovascular incidents and fatalities within New Jersey, ultimately improving public health outcomes.

Summary

SCR38 is a Concurrent Resolution that aims to address the rising fatalities caused by atherosclerotic cardiovascular disease (ASCVD), which is recognized as the leading cause of death in the United States. The resolution urges the Governor of New Jersey to direct relevant state departments and agencies to collaborate and enhance cardiovascular health screening programs. With a significant number of adults affected by ASCVD and the escalating costs associated with its treatment, this resolution seeks to take proactive measures to alleviate the impact of this health issue on the state's population and health system.

Sentiment

The sentiment surrounding SCR38 is largely supportive, as it tackles a pressing public health issue with potential to save lives. Legislators and health advocates share a recognition of the urgent need to confront ASCVD, particularly given its documented prevalence and the substantial economic burden it places on the state’s healthcare system. Stakeholders across the spectrum appear to understand the importance of collaborative efforts in this domain, viewing the resolution as a commendable step towards better healthcare for New Jersey residents.

Contention

While SCR38 has gained broad support, potential points of contention may arise in the implementation phase, particularly concerning the allocation of resources and the specific strategies employed by state departments to execute the screening programs. Critics might voice concerns regarding the efficiency and effectiveness of government-led health initiatives, especially if they believe that local approaches may be better suited to address the unique health needs of different communities. Furthermore, as with many public health initiatives, there may be discussions around funding and prioritization amidst other pressing health issues.

Companion Bills

NJ SCR146

Carry Over Urges Governor to direct all relevant State departments and agencies to help decrease number of fatalities caused by atherosclerotic cardiovascular disease.

Similar Bills

NJ SCR146

Urges Governor to direct all relevant State departments and agencies to help decrease number of fatalities caused by atherosclerotic cardiovascular disease.

NJ ACR186

Urges Governor to direct all relevant State departments and agencies to help decrease number of fatalities caused by atherosclerotic cardiovascular disease.

CA ACR67

Atherosclerotic cardiovascular disease (ASCVD).

TX HR435

Urging the Texas Department of State Health Services and the Texas Health and Human Services Commission to expand their comprehensive cardiovascular screening programs.

NV SCR5

Urges the expansion of comprehensive cardiovascular screening programs and directs the Joint Interim Standing Committee on Health and Human Services to conduct a study concerning such programs and certain other matters relating to cardiovascular disease. (BDR R-1025)

PA HR171

Designating the month of June 2023 as "Atherosclerotic Cardiovascular Disease Month" in Pennsylvania.

PA SR56

Designating the month of February 2023 as "Atherosclerotic Cardiovascular Disease Month" in Pennsylvania.

MA S1964

Resolutions to improve the care of atherosclerotic cardiovascular disease